Using enriched observational data to develop and validate age-specific mortality risk adjustment models for

Ying P Tabak1, Xiaowu Sun, Linda Hyde

  • 1CareFusion, Clinical Research, San Diego, CA 92130, USA. ying.tabak@carefusion.com

Medical Care
|April 5, 2013
PubMed

Insights

Developing age-specific models using physiological data significantly improves mortality risk prediction in hospitalized children. These tools enhance pediatric outcome analysis and comparative effectiveness research.

Area of Science:

  • Pediatric critical care medicine
  • Health informatics
  • Biostatistics

Background:

  • Early childhood growth involves rapid physiological changes.
  • Accurate mortality risk adjustment is crucial for hospitalized pediatric patients.
  • Existing models often rely heavily on administrative data, potentially missing key physiological indicators.

Purpose of the Study:

  • To develop and validate age-specific mortality risk adjustment models for pediatric hospitalizations.
  • To incorporate objective physiological variables alongside administrative data.
  • To improve the accuracy of risk prediction in diverse pediatric age groups.

Main Methods:

  • Created age-specific models for neonates, infants/toddlers, and children.
  • Utilized logistic regression on derivation cohorts (2000-2001) and validated on separate cohorts (2002-2007).
  • Assessed model performance using the c statistic and analyzed variable contributions.

Main Results:

  • Models demonstrated high predictive accuracy (c statistics ranging from 0.86 to 0.94).
  • Physiological variables were major contributors to model fit, especially in infants/toddlers (93%) and children (82%).
  • Mortality rates varied across age groups in both derivation and validation cohorts.

Conclusions:

  • Age-specific physiological determinants are critical for accurate mortality prediction in children.
  • Developed models offer practical utility for risk adjustment and comparative effectiveness research.
  • Electronic medical record integration of physiological data enhances model applicability.
Abstract

Related Concept Videos

Comparing the Survival Analysis of Two or More Groups01:20

Comparing the Survival Analysis of Two or More Groups

Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and Cox...
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion01:18

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion

In geriatric patients, renal physiology undergoes significant changes, including diminished renal blood flow and a lower glomerular filtration rate (GFR), leading to alterations in medication clearance. Drugs such as aminoglycoside antibiotics, lithium, and digoxin, which rely on glomerular filtration for removal from the body, particularly impact pharmacokinetics. These drugs tend to have slower clearance rates in older adults, necessitating careful dosage considerations.Evaluation of renal...
Actuarial Approach01:20

Actuarial Approach

The actuarial approach, a statistical method originally developed for life insurance risk assessment, is widely used to calculate survival rates in clinical and population studies. This method accounts for participants lost to follow-up or those who die from causes unrelated to the study, ensuring a more accurate representation of survival probabilities.
Consider the example of a high-risk surgical procedure with significant early-stage mortality. A two-year clinical study is conducted,...
Kaplan-Meier Approach01:24

Kaplan-Meier Approach

The Kaplan-Meier estimator is a non-parametric method used to estimate the survival function from time-to-event data. In medical research, it is frequently employed to measure the proportion of patients surviving for a certain period after treatment. This estimator is fundamental in analyzing time-to-event data, making it indispensable in clinical trials, epidemiological studies, and reliability engineering. By estimating survival probabilities, researchers can evaluate treatment effectiveness,...
Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration01:28

Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration

Glomerular filtration rate (GFR) can be estimated from serum creatinine using the modification of diet in renal disease (MDRD) formula or the chronic kidney disease–epidemiology collaboration (CKD–EPI) equation. Both methods are widely used in clinical practice to assess kidney function and guide treatment decisions.The MDRD equation does not require weight or height measurements and is normalized to the body surface area of 1.73 m², considered the average adult surface area. This equation is...
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...